PD-L1 expression and pattern of immune cells in pre-treatment specimens are associated with disease-free survival for HR-NMIBC undergoing BCG treatment
M. Roumiguié, Éva Compérat, Léonor Chaltiel, François Xavier Nouhaud, G. Verhoest, A. Masson-Lecomte, Pierre Colin, François Audenet, Nadine Houédé, S. Larré, Évanguelos Xylinas, Serge Brunelle, Jeanne Piana-Thomassin, Juliette Cotte, G. Pignot, Y. Neuzillet, Morgan Rouprêt
Topics & Concepts
MedicineInternal medicineProportional hazards modelNephrologyBladder cancerStage (stratigraphy)ConcomitantGastroenterologyUrologyHazard ratioLog-rank testRetrospective cohort studyOncologyCancerConfidence intervalPaleontologyBiologyBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersUrinary and Genital Oncology Studies